首页> 外文期刊>Advances in Interventional Cardiology: Postepy w Kardiologii Interwencyjnej >Pulmonary vein isolation in a patient with atrial fibrillation and a filter in the inferior vena cava
【24h】

Pulmonary vein isolation in a patient with atrial fibrillation and a filter in the inferior vena cava

机译:房颤患者并有下腔静脉滤器的肺静脉隔离

获取原文
获取外文期刊封面目录资料

摘要

A 60-year-old man with a 1-year history of highly symptomatic drug-resistant paroxysmal atrial fibrillation (AF) was admitted for pulmonary vein isolation (PVI). In 1984 the patient had hemorrhagic stroke of the left hemisphere with right-sided hemiparesis that was complicated with pulmonary embolism. Therefore the patient was treated with surgical implantation of a prototype filter to the vena cava inferior (VCI). His medical history included hypertension, diabetes mellitus, transient ischemic attack and epilepsy. Using the transfemoral approach under fluoroscopic guidance, the diagnostic catheter was placed in the coronary sinus. Crossing the filter with the long guidewire of the transseptal sheath (8.5 Fr SL0, St Jude Medical, Minnetonka, MN, USA) turned out to be impossible. To overcome this problem we advanced the transseptal sheath over the guidewire next to the filter and only then managed to pass the guidewire (and then the sheath) by the filter (Figure 1). Double transseptal puncture was performed successfully. Using the CARTO system, Lasso diagnostic catheter (Biosense Webster, Diamond Bar, Ca, USA) and Navistar ThermoCool Smarttouch ablation catheter (Biosense Webster, Diamond Bar, Ca, USA), successful PVI was performed. The overall procedure time was 215 min. Total fluoroscopy exposure was 31 min and 53 s (6141.9 cGy ? cm2). During 12 months of follow-up there was no AF (24-hour ECG monitoring at 3, 6, 9, and 12 months after ablation). The VCI filters are inserted for prevention of pulmonary embolus from lower extremity deep vein thrombosis [1]. Presence of a VCI filter has traditionally been considered a relative contraindication for catheterization from the femoral vein [2]. To our knowledge, this is the first case of successful PVI in a patient with AF and presence of an unknown type of filter in the VCI. The decision to perform the catheter procedure largely depends on the filter type in the VCI. Over the past decade, there has been a gradual evolution of VCI filters [3]. Limited data are available on complicating the standard procedure catheterization across the filter in the VCI [4]. During crossing the filter we used continuous fluoroscopy to reduce the risk of adverse events. It was necessary to bring the sheath close to the filter. The solution was to use a straight guidewire for passage of the filter. All maneuvers were performed without filter dislodgment.
机译:一名60岁男性,有1年的高度症状性耐药性阵发性心房颤动(AF)病史被允许进行肺静脉隔离(PVI)。 1984年,患者左半球出血性中风伴右侧偏瘫,并发肺栓塞。因此,通过外科手术将原型过滤器植入下腔静脉(VCI)来治疗该患者。他的病史包括高血压,糖尿病,短暂性脑缺血发作和癫痫病。在荧光镜引导下使用经股动脉入路,将诊断导管放置在冠状窦内。事实证明,使过滤器与跨隔鞘的长导丝(8.5 Fr SL0,St Jude Medical,Minnetonka,MN,美国)交叉是不可能的。为了克服这个问题,我们将隔壁鞘膜移到了靠近过滤器的导丝上,然后才设法使导丝(然后是鞘膜)通过了滤器(图1)。成功进行了两次经隔穿刺。使用CARTO系统,套索诊断导管(美国加利福尼亚州戴蒙德·巴恩斯,韦伯斯特,美国)和Navistar ThermoCool Smarttouch消融导管(美国加利福尼亚州戴维斯·巴恩森斯,韦伯斯特),成功完成了PVI。整个过程时间为215分钟。荧光透视图总曝光时间为31分钟和53秒(6141.9 cGy?cm2)。在随访的12个月中,未发生房颤(消融后3、6、9和12个月进行24小时ECG监测)。插入VCI过滤器可防止下肢深静脉血栓形成引起的肺栓塞[1]。传统上,VCI过滤器的存在被认为是从股静脉进行导管插入术的相对禁忌症[2]。据我们所知,这是房颤患者在VCI中成功存在PVI的第一例。执行导管程序的决定很大程度上取决于VCI中的过滤器类型。在过去的十年中,VCI滤波器逐渐发展[3]。在VCI中,通过过滤器使标准程序导管插入变得复杂的数据有限[4]。在穿过过滤器的过程中,我们使用了连续透视检查以减少不良事件的风险。必须使护套靠近过滤器。解决方案是使用直的导丝使过滤器通过。所有操作均未发生过滤器移位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号